Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Best of the IASLC 17th World Conference on Lung Cancer in Lima, Peru, February 2017
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
2017 ASCO Annual Meeting
7th IASLC Latin American Conference on Lung Cancer
Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune Checkpoint Inhibitor Therapy
First Congress of Interventional Pulmonology & EBUS and the XI South...
lungcanc
WCLC 2016 Together Against Lung Cancer
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
lungcanc
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient...
lungcanc
IASLC 2019 World Conference on Lung Cancer: Collaborative Formats, Novel Data
lungcanc
IASLC WCLC 2016: Active Prevention, Accurate Diagnosis, Advanced Care
lungcanc
Lung Cancer Immunotherapy Meeting to Discuss New Topics, Emerging Themes
lungcanc
Highlights from the NCI Post-Treatment Surveillance Workshop
lungcanc
Highlights from IASLC WCLC 2016
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS